AUSTIN, Texas--(BUSINESS WIRE)--CEDRA Corporation, a division of Worldwide Clinical Trials and provider of Phase I-IIb clinical research and bioanalytical services, is pleased to announce the appointment of CEDRA’s Senior Director of Business Development in Generics, John F. Pottier.
